Federal Supreme Court: health insurers must reimburse medical cannabis

A landmark ruling (BGE 9C_412/2025) requires health insurers to reimburse medical cannabis therapies for clearly defined indications.

On 5 June 2026, in ruling 9C_412/2025, the Swiss Federal Supreme Court held that the mandatory basic health insurance (OKP/AOS) must cover medical cannabis in medically justified cases.

Insurers have 90 days to adapt their internal guidelines. The precedent concerned a patient with treatment-resistant spasticity in multiple sclerosis.